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1726-4Predictor for recurrent colorectal adenoma after screening
colonoscopyColorectal cancer (CRC) is one of the leading causes of
cancer-related deaths worldwide.1 Although the incidence and
mortality of CRC are gradually decreasing in Europe and
North America,2 which may be the result of broadly promoted
screening programs, incidence and mortality rate of CRC
continue to increase in Asia.3 In Taiwan, CRC is the most
common malignancy and the second most common cause of
cancer-related deaths based on a report from the Bureau of
Health Promotion.4 Detecting and removing an adenoma by
screening colonoscopy is an effective strategy for reducing the
incidence and mortality of CRC.5 After an initial colonoscopy,
20e50% of the screened patients will be found to have a
recurrent adenoma or more advanced lesions (>25% villous
histology, and/or size >1 cm, and/or presence of high-grade
dysplasia) or even CRC on a surveillance colonoscopy
within 3e5 years.6 Therefore, it is recommended that ade-
noma patients should undergo regular surveillance colono-
scopy. Notwithstanding this recommendation, however,
colonoscopy surveillance brings a significant burden to both
society and patients in terms of medical resources, costs, and
potential procedure-related complications.7 It is therefore
important to identify predictive factors for adenoma recur-
rence in order to enhance the efficacy of surveillance and risk
stratification. Current evidence has suggested that the factors
predicting adenoma recurrence may be patient-related (age,
sex, metabolic syndrome), adenoma-related (size, number,
histology), or colonoscopy-related (location, adequacy of
bowel preparation).8,9 Nevertheless, conclusive evidence for
proper risk stratification for index findings at baseline colo-
noscopy are lacking.
In this issue of the Journal of the Chinese Medical Asso-
ciation, Lin and colleagues10 attempted to identify the pre-
dictors of recurrent adenoma after initial screening
colonoscopy with adenoma polypectomy in a group of
average-risk individuals receiving self-paid health check-ups.
In this retrospective study, 356 out of 2255 individuals were
found to have colonic adenoma at baseline colonoscopy when
excluding those who have long-term usage of aspirin or non-
steroidal antiinflammatory drugs. During a follow-up interval
of 3.07 years, 94 (26.4%) individuals had recurrent adenoma.
After employing use of the Cox regression analysis, hyper-
tension, smoking, higher serum Alanine transaminase (ALT)x.doi.org/10.1016/j.jcma.2014.07.007
901/Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Asslevels, and a multiple-located adenoma were the independent
predictors for recurrent colorectal adenoma. The authors
emphasized the importance of hypertension in prediction of
recurrent colorectal adenoma, since its risk increased when
hypertension was combined with other independent factors.
Interestingly, metabolic syndrome was not an independent
predicting factor in this study.
Although conflicting study results exist, hypertension has
been found to be a risk factor for colorectal adenoma or even
CRC.10 The current study may be the first to show a possible
role of hypertension as a predictor for recurrent colorectal
adenoma among individuals receiving polypectomy with
colonic adenoma at initial colonoscopy. Hypertension has
been suggested to increase cancer risk by blocking and sub-
sequently modifying apoptosis, thereby affecting cell turn-
over.11 Despite this fact, the potential mechanism behind the
association of hypertension and recurrent adenoma remained
unknown. Furthermore, it seemed that controlling hyper-
tension did not decrease the risk, because >50% of the indi-
viduals had taken antihypertensive drugs and still had
recurrent colorectal adenoma. The finding suggested that the
increased risk of recurrent adenoma in patients with hyper-
tension may be inherited, and may not be modified.
A large number of epidemiological studies support the
proposition that metabolic syndrome, a cluster of car-
diovascular risk factors including insulin resistance, dyslipi-
demia, obesity, and hypertension, is a predictor for both
colorectal adenoma and CRC.12 A recent meta-analysis also
revealed that metabolic syndrome was associated with a 34%
increase in the risk of colonic neoplasm (both CRC and col-
orectal adenoma).13 For recurrent colorectal adenoma, meta-
bolic syndrome and obesity were significantly associated with
its development in Korean adult males.14 A recent study in
abstract form from Taiwan also found that metabolic syn-
drome is an independent risk factor for incident advanced
adenoma after a “negative” colonoscopy.15 In contrast to the
two earlier reports, the current study demonstrated that met-
abolic syndrome was not a predictor of recurrent colorectal
adenoma. The reason for the discrepancy among these three
Asian studies is unclear. However, the difference in follow-up
period may be a factor because a mean duration of 4.8 years
follow-up was noted in the Korean study whereas 3.07 yearsociation. All rights reserved.
502 Editorial / Journal of the Chinese Medical Association 77 (2014) 501e502was noted in the current one. A longer period of time may be
required for the development and detection of recurrent ade-
noma among patients with metabolic syndrome. More studies
are mandatory to clarify this issue.
In conclusion, it is important to identify the baseline
parameters that are risk factors for adenoma findings on sur-
veillance colonoscopy, to recognize high risk patients who
need more vigilant surveillance colonoscopy, and to tailor
guidelines in colonoscopy surveillance after polypectomy.
Hypertension may be a potential predictive risk factor of
recurrent colorectal adenoma in individuals that underwent
polypectomy at baseline colonoscopy.
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